
New York Faces a Rising Superbug Challenge Fueled by Antibiotic Misuse
New York is confronting a surge in the drug‑resistant fungus Candida auris and other 'nightmare bacteria'; infections are rising, largely driven by improper antibiotic use, while experts urge better antibiotic stewardship, the development of new drugs, and the PASTEUR Act to stabilize the market and spur research. Statewide last year recorded 623 clinical and 849 surveillance Candida auris cases, with the NYC metro area accounting for about 20% of US cases.












